A novel Staphylococcus podophage encodes a unique lysin with unusual modular design

mSphere

Volumn 2, Issue 2, 2017, Pages

  Cater, Katie ^a   Dandu, Vidya Sree ^a   Bari, S M Nayeemul ^a   Lackey, Kim ^a   Everett, Gabriel F K ^b,c   Hatoum Aslan, Asma ^a  

^a UNIVERSITY OF ALABAMA   (United States)

^b TEXAS A AND M UNIVERSITY   (United States)

^c NCH Corporation   (United States)

Author keywords

Antimicrobial agents; Bacteriophage lysis; Bacteriophage therapy; Bacteriophages; Staphylococcus

Indexed keywords

EID: 85038633218     PISSN: None     EISSN: 23795042     Source Type: Journal    
DOI: 10.1128/mSphere.00040-17     Document Type: Article

References (24)

1. Rossolini GM, Arena F, Pecile P, Pollini S. 2014. Update on the antibiotic resistance crisis. Curr Opin Pharmacol 18:56-60. https://doi.org/10.1016/ j.coph.2014.09.006
2. Lowy FD. 1998. Staphylococcus aureus infections. N Engl J Med 339: 520-532. https://doi.org/10.1056/NEJM199808203390806
3. Kluytmans J, van Belkum A, Verbrugh H. 1997. Nasal carriage of Staphylococcus aureus: epidemiology, underlying mechanisms, and associated risks. Clin Microbiol Rev 10:505-520
4. Peacock SJ, de Silva I, Lowy FD. 2001. What determines nasal carriage of Staphylococcus aureus? Trends Microbiol 9:605-610. https://doi.org/10 .1016/S0966-842X(01)02254-5
5. Otto M. 2009. Staphylococcus epidermidis-the "accidental" pathogen. Nat Rev Microbiol 7:555-567. https://doi.org/10.1038/nrmicro2182
6. CDC. 2004. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1992 through June 2004, issued October 2004. Am J Infect Control 32:470-485. https://doi.org/10.1016/ S0196655304005425
7. Knox J, Uhlemann AC, Lowy FD. 2015. Staphylococcus aureus infections: transmission within households and the community. Trends Microbiol 23:437-444. https://doi.org/10.1016/j.tim.2015.03.007
8. Borysowski J, Lobocka M, Miedzybrodzki R, Weber-Dabrowska B, Górski A. 2011. Potential of bacteriophages and their lysins in the treatment of MRSA. Biodrugs 25:347-355. https://doi.org/10.2165/11595610-000000000-00000
9. Kazmierczak Z, Górski A, Dabrowska K. 2014. Facing antibiotic resistance: Staphylococcus aureus phages as a medical tool. Viruses 6:2551-2570. https://doi.org/10.3390/v6072551
10. Fischetti VA. 5 January 2016. Lysin therapy for Staphylococcus aureus and other bacterial pathogens. Curr Top Microbiol Immunol https://doi .org/10.1007/82_2015_5005
11. Kwan T, Liu J, Dubow M, Gros P, Pelletier J. 2005. The complete genomes and proteomes of 27 Staphylococcus aureus bacteriophages. Proc Natl Acad Sci U S A 102:5174-5179. https://doi.org/10 .1073/pnas.0501140102
12. Deghorain M, Van Melderen L. 2012. The staphylococci phages family: an overview. Viruses 4:3316-3335. https://doi.org/10.3390/v4123316
13. Brüssow H, Canchaya C, Hardt WD. 2004. Phages and the evolution of bacterial pathogens: from genomic rearrangements to lysogenic conversion. Microbiol Mol Biol Rev 68:560-602. https://doi.org/10.1128/ MMBR.68.3.560-602.2004
14. Cooper CJ, Mirzaei MK, Nilsson AS. 2016. Adapting drug approval pathways for bacteriophage-based therapeutics. Front Microbiol 7:1209. https://doi.org/10.3389/fmicb.2016.01209
15. Schmelcher M, Shen Y, Nelson DC, Eugster MR, Eichenseher F, Hanke DC, Loessner MJ, Dong S, Pritchard DG, Lee JC, Becker SC, Foster-Frey J, Donovan DM. 2015. Evolutionarily distinct bacteriophage endolysins featuring conserved peptidoglycan cleavage sites protect mice from MRSA infection. J Antimicrob Chemother 70:1453-1465. https://doi.org/ 10.1093/jac/dku552
16. Marraffini LA, Sontheimer EJ. 2008. CRISPR interference limits horizontal gene transfer in staphylococci by targeting DNA. Science 322: 1843-1845. https://doi.org/10.1126/science.1165771
17. Young RY. 1992. Bacteriophage lysis: mechanism and regulation. Microbiol Rev 56:430-481
18. Son JS, Lee SJ, Jun SY, Yoon SJ, Kang SH, Paik HR, Kang JO, Choi YJ. 2010. Antibacterial and biofilm removal activity of a Podoviridae Staphylococcus aureus bacteriophage SAP-2 and a derived recombinant cell-walldegrading enzyme. Appl Microbiol Biotechnol 86:1439-1449. https://doi .org/10.1007/s00253-009-2386-9
19. Linden SB, Zhang H, Heselpoth RD, Shen Y, Schmelcher M, Eichenseher F, Nelson DC. 2015. Biochemical and biophysical characterization of PlyGRCS, a bacteriophage endolysin active against methicillin-resistant Staphylococcus aureus. Appl Microbiol Biotechnol 99:741-752. https:// doi.org/10.1007/s00253-014-5930-1
20. Farris MH, Ford KA, Doyle RC. 2016. Qualitative and quantitative assays for detection and characterization of protein antimicrobials. J Vis Exp 110:e53819. https://doi.org/10.3791/53819
21. Daniel A, Euler C, Collin M, Chahales P, Gorelick KJ, Fischetti VA. 2010. Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus. Antimicrob Agents Chemother 54:1603-1612. https://doi.org/10.1128/ AAC.01625-09
22. Li L, Zhang Z. 2014. Isolation and characterization of a virulent bacteriophage SPW specific for Staphylococcus aureus isolated from bovine mastitis of lactating dairy cattle. Mol Biol Rep 41:5829-5838. https://doi .org/10.1007/s11033-014-3457-2
23. Summer EJ. 2009. Preparation of a phage DNA fragment library for whole genome shotgun sequencing, p 27-46. In Clokie MRJ, Kropinski AM (ed), Bacteriophages: methods and protocols, vol 2. Molecular and applied aspects. Humana Press, Totowa, NJ
24. Walker FC, Chou-Zheng L, Dunkle JA, Hatoum-Aslan A. 3 October 2016. Molecular determinants for CRISPR RNA maturation in the Cas10-Csm complex and roles for non-Cas nucleases. Nucleic Acids Res https://doi .org/10.1093/nar/gkw891